CA
NZ
UK
AU
IND
US
…
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Publicly available information on WORK Medical Technology Group Ltd is limited; it is listed on NASDAQ and described in company filings as a medical technology company. Long-term growth drivers that could support the business include demographic aging and rising healthcare demand, and investors may find exposure to medical-device innovation and healthcare end-markets potentially attractive.
Material risks include limited disclosure and low trading liquidity, regulatory and geopolitical exposure common to U.S.-listed foreign medical companies, and execution and financial uncertainty.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Income before tax | -1.08M | -3.67M | 0.11M | 1.11M | 7.34M |
| Minority interest | 0.13M | 0.05M | 0.05M | -0.08M | -0.31M |
| Net income | -1.07M | -3.49M | 0.11M | 0.87M | 5.96M |
| Selling general administrative | 2.33M | 4.56M | 1.86M | 2.56M | 2.89M |
| Selling and marketing expenses | 2.08M | 2.05M | 1.57M | 1.03M | 1.59M |
| Gross profit | 2.34M | 2.87M | 4.14M | 4.42M | 8.64M |
| Reconciled depreciation | 0.92M | 1.41M | 1.60M | 3.26M | 4.19M |
| Ebit | -0.58M | -3.11M | 0.48M | 1.46M | 7.67M |
| Ebitda | 0.34M | -1.71M | 2.08M | 4.72M | 11.87M |
| Depreciation and amortization | 0.92M | 1.39M | 1.60M | 3.26M | 4.19M |
| Operating income | -2.50M | -3.70M | 0.49M | 1.82M | 7.67M |
| Other operating expenses | 12.34M | 15.21M | 13.08M | 17.89M | 38.19M |
| Interest expense | 0.50M | 0.56M | 0.37M | 0.35M | 0.33M |
| Tax provision | 0.12M | -0.13M | 0.05M | 0.17M | 1.08M |
| Interest income | 0.18M | 0.01M | 0.03M | 0.00M | - |
| Net interest income | -0.32M | -0.55M | -0.37M | -0.35M | -0.33M |
| Income tax expense | 0.12M | -0.13M | 0.05M | 0.17M | 1.08M |
| Total revenue | 9.85M | 11.51M | 13.57M | 19.71M | 45.86M |
| Total operating expenses | 4.84M | 6.57M | 3.66M | 2.59M | 0.97M |
| Cost of revenue | 7.50M | 8.64M | 9.42M | 15.29M | 37.22M |
| Total other income expense net | 1.41M | 0.38M | -0.38M | 0.48M | 3.38M |
| Net income from continuing ops | -1.20M | -3.54M | 0.06M | 0.94M | 6.27M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Total assets | 33.16M | 36.25M | 29.96M | 25.54M | 30.66M |
| Intangible assets | 0.96M | 1.04M | 1.00M | 0.95M | 1.06M |
| Other current assets | 0.23M | 5.33M | 4.95M | 5.37M | 4.77M |
| Total liab | 11.99M | 20.18M | 18.97M | 14.35M | 19.26M |
| Total stockholder equity | 18.35M | 13.19M | 9.88M | 10.00M | 10.04M |
| Other current liab | 3.43M | 2.22M | 3.01M | 2.35M | 1.13M |
| Common stock | 0.05M | 0.01M | 0.01M | 0.01M | 0.05M |
| Capital stock | 0.05M | 0.01M | 0.01M | 0.01M | 0.05M |
| Retained earnings | 4.96M | 6.08M | 9.58M | 9.51M | 8.74M |
| Cash | 4.09M | 6.56M | 1.60M | 0.73M | 0.51M |
| Total current liabilities | 11.97M | 20.18M | 18.92M | 14.26M | 18.91M |
| Current deferred revenue | 0.40M | 0.63M | 0.78M | 0.74M | 1.59M |
| Net debt | 2.36M | 6.91M | 7.50M | 5.57M | 6.09M |
| Short term debt | 6.41M | 13.47M | 9.05M | 6.23M | 6.60M |
| Short long term debt | 6.39M | 13.47M | 8.84M | 5.97M | 6.60M |
| Short long term debt total | 6.45M | 13.47M | 9.10M | 6.30M | 6.60M |
| Other stockholder equity | 13.04M | 6.61M | 0.08M | 0.08M | 0.04M |
| Total current assets | 20.46M | 20.83M | 22.15M | 16.61M | 18.15M |
| Net receivables | 12.45M | 5.75M | 10.99M | 6.15M | 6.57M |
| Inventory | 3.68M | 3.18M | 4.62M | 4.36M | 6.29M |
| Accounts payable | 1.72M | 1.50M | 3.96M | 3.20M | 9.04M |
| Accumulated other comprehensive income | 0.29M | 0.49M | 0.21M | 0.41M | 1.21M |
| Non currrent assets other | 1.13M | - | - | - | - |
| Non current assets total | 12.71M | 15.42M | 7.81M | 8.93M | 12.51M |
| Capital lease obligations | 0.03M | 0.00M | 0.10M | 0.09M | 0.00M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Investments | - | -9.06M | -0.58M | -1.35M | -0.06M |
| Total cashflows from investing activities | -7.61M | -9.06M | -0.58M | -1.35M | -0.06M |
| Net borrowings | -5.79M | 1.05M | -5.26M | -9.69M | 2.24M |
| Total cash from financing activities | -0.90M | 15.66M | -0.73M | 3.57M | 7.99M |
| Net income | -1.07M | -3.49M | 0.06M | 0.94M | 6.27M |
| Change in cash | -2.87M | 4.92M | 0.86M | -0.10M | 0.67M |
| Begin period cash flow | 6.96M | 1.64M | 0.77M | 0.87M | 0.20M |
| End period cash flow | 4.09M | 6.56M | 1.64M | 0.77M | 0.87M |
| Total cash from operating activities | 6.24M | -2.23M | 2.21M | -2.26M | -7.18M |
| Issuance of capital stock | 6.90M | 7.37M | 0.00M | 0.00M | 0.79M |
| Depreciation | 0.92M | 1.39M | 1.60M | 3.26M | 4.19M |
| Other cashflows from investing activities | -6.66M | 0.16M | -0.13M | 0.60M | 0.16M |
| Change to inventory | 0.57M | 1.58M | -0.40M | 2.05M | 6.89M |
| Change to account receivables | 1.02M | 1.82M | -0.13M | -3.96M | -0.12M |
| Other cashflows from financing activities | -1.63M | 7.23M | -3.84M | 13.26M | 4.96M |
| Capital expenditures | 1.33M | 9.26M | 0.58M | 2.01M | 0.06M |
| Change in working capital | 6.44M | -0.11M | 0.46M | -7.13M | -18.16M |
| Other non cash items | -0.15M | 0.02M | 0.18M | 0.98M | 0.64M |
| Free cash flow | 4.91M | -11.49M | 1.63M | -4.27M | -7.24M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| WOK WORK Medical Technology Group LTD Ordinary Shares |
0.02 2.62% |
0.94 | - | - | 0.76 | 0.28 | 1.11 | 23.10 |
| ABT Abbott Laboratories |
-2.16 1.90% |
111.44 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
-2.29 2.18% |
102.55 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-9.53 2.84% |
325.55 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
-2.15 4.12% |
49.85 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
| Name | Title | Year Born |
|---|---|---|
| Mr. Shuang Wu | Chairman & CEO | 1983 |
| Mr. Ningfang Liang | Chief Financial Officer | 1972 |
| Mr. Baiming Yu | COO & Director | 1971 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.05%
Communication Services
-0.31%
Consumer Cyclical
-0.13%
Consumer Defensive
-0.27%
Energy
+0.32%
Financial Services
-0.36%
Financials
+1.03%
Healthcare
+0.41%
Industrials
+0.22%
Real Estate
-0.31%
Technology
+1.01%
Utilities
+0.00%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...